Phase 2 Study of Aficamten in Patients With Obstructive Hypertrophic CardiomyopathyMartin S. Maron, Theodore P. Abraham, Anjali Owens et al.|Journal of the American College of Cardiology|2023Cited by 192
Primary Left Atrial Cardiopathy in Transthyretin Amyloidosis Cardiomyopathy by Multimodality ImagingBenay Özbay, Leyla Elif Sade, Corey Rearick et al.|JACC. Cardiovascular imaging|2025Cited by 7
CMR and adverse clinical outcomes in peripartum cardiomyopathyAgnes Koczo, Timothy C. Wong, Deeksha Acharya et al.|American Heart Journal Plus Cardiology Research and Practice|2024Cited by 1
Effects of mavacamten on left atrial function in hypertrophic obstructive cardiomyopathyBenay Özbay, Leyla Elif Sade, Natarajan Venkatesan et al.|European Heart Journal - Cardiovascular Imaging|2025Cited by 1
Guideline-directed medical therapy in heart failure in older adults; any differences in varies age group?Stefan L.S. Kwa, I.C. Yew, Brile Chung et al.|International Journal of Cardiology|2024Cited by 0